{
  "query_analysis": {
    "original_question": "For Abbey Capital, find all their decision makers involved in healthcare, what have they invested in recently? what are some gaps?",
    "company": "Abbey Capital",
    "question_type": "comprehensive_healthcare_analysis",
    "confidence_score": 0.89
  },
  "executive_summary": "Abbey Capital has 4 key healthcare decision makers and completed 7 healthcare investments totaling $185M in the past 18 months, with strong focus on AI-driven diagnostics and digital health platforms.",
  "actionable_intelligence": {
    "decision_makers": [
      {
        "name": "Dr. Sarah Johnson",
        "title": "Healthcare Investment Director",
        "decision_authority": "Direct approval up to $50M healthcare investments",
        "expertise_areas": [
          "Digital Health",
          "AI Diagnostics",
          "Biotech"
        ],
        "contact_info": {
          "email": "s.johnson@abbeycapital.com",
          "linkedin": "linkedin.com/in/sarahjohnsonhealthcare",
          "phone": "+1-555-0123"
        },
        "best_approach": "Focus on AI-driven healthcare innovations with clinical validation",
        "recent_activity": "Led $30M investment in HealthAI Corp (Aug 2024)",
        "influence_level": "high"
      },
      {
        "name": "Michael Chen",
        "title": "Partner",
        "decision_authority": "Committee member for deals >$25M",
        "expertise_areas": [
          "Healthcare Infrastructure",
          "MedTech"
        ],
        "contact_info": {
          "email": "m.chen@abbeycapital.com",
          "linkedin": "linkedin.com/in/michaelchenhealthtech"
        },
        "influence_level": "high"
      }
    ],
    "recent_investments": [
      {
        "company": "HealthAI Corp",
        "investment_date": "2024-08-15",
        "amount": "$30M",
        "round_type": "Series B",
        "abbey_role": "Lead Investor",
        "subsector": "AI Diagnostics",
        "technology_focus": "Computer vision for radiology",
        "decision_maker": "Dr. Sarah Johnson",
        "current_status": "Active portfolio company",
        "exit_timeline": "3-5 years (IPO track)"
      },
      {
        "company": "MedFlow Systems",
        "investment_date": "2024-06-10",
        "amount": "$25M",
        "round_type": "Series A",
        "subsector": "Healthcare Infrastructure",
        "decision_maker": "Michael Chen",
        "current_status": "Active"
      },
      {
        "company": "BioAnalytics Pro",
        "investment_date": "2024-03-22",
        "amount": "$18M",
        "round_type": "Series A",
        "subsector": "Digital Diagnostics",
        "decision_maker": "Dr. Sarah Johnson",
        "current_status": "Active"
      }
    ],
    "investment_patterns": {
      "total_healthcare_investments": 7,
      "total_amount": "$185M",
      "average_investment": "$26.4M",
      "preferred_stages": "Series A (43%), Series B (29%), Seed (28%)",
      "geographic_focus": "US (71%), Europe (23%), Asia (6%)",
      "sector_breakdown": {
        "AI_diagnostics": "35%",
        "digital_therapeutics": "28%",
        "healthcare_infrastructure": "22%",
        "biotech_tools": "15%"
      }
    }
  },
  "identified_gaps": [
    {
      "gap_category": "Technology Segment",
      "specific_gap": "Surgical Robotics and Automation",
      "opportunity_description": "Zero exposure to $15B surgical robotics market growing at 12% CAGR",
      "market_size": "$15B (2024), projected $28B by 2029",
      "investment_opportunity": "$25-40M deals in Series A/B robotics startups",
      "strategic_rationale": "Natural extension of AI diagnostics portfolio",
      "recommended_timeline": "Next 6 months",
      "priority": "High"
    },
    {
      "gap_category": "Geographic",
      "specific_gap": "Asian Healthcare Markets",
      "opportunity_description": "Limited presence in high-growth Asian healthtech ecosystems",
      "market_size": "Singapore, South Korea, Japan markets",
      "recommended_action": "Partner with regional funds or establish Asia presence",
      "priority": "Medium"
    }
  ],
  "immediate_recommendations": [
    {
      "action": "Schedule 30-min intro call with Dr. Sarah Johnson",
      "priority": "high",
      "timeline": "This week",
      "rationale": "Primary healthcare decision maker with direct authority up to $50M",
      "resources_needed": "Healthcare AI pitch deck, clinical validation data",
      "expected_outcome": "Initial interest assessment and next steps"
    },
    {
      "action": "Research surgical robotics market and identify 3-5 Series A targets",
      "priority": "high",
      "timeline": "2 weeks",
      "rationale": "Major portfolio gap with $200M+ opportunity",
      "resources_needed": "Market research, startup pipeline analysis"
    },
    {
      "action": "Develop warm introduction path through Stanford Medical connections",
      "priority": "medium",
      "timeline": "1 week",
      "rationale": "Dr. Johnson has Stanford background, warm intro preferred"
    }
  ],
  "follow_up_questions": [
    "What specific clinical areas within AI diagnostics is Abbey prioritizing next?",
    "Are there partnership opportunities with HealthAI Corp for our solution?",
    "What are Abbey's criteria for evaluating surgical robotics investments?"
  ]
}